Hing C. Wong is listed as an executive officer and director on 17 SEC Form D filings by 2 issuers between Oct 2009 and Oct 2026: Altor Bioscience Corp (Miramar, FL — biotechnology — 2009–2017; $30.3M reported sold to 29 investors) and HCW Biologics Inc. (Miramar, FL — biotechnology — 2020–2026; $6.92M reported sold to 9 investors).
What this means 2 separate companies raised money with this person listed as executive officer and director, over about 17 years. Across those companies the filings report $37.2M sold in total.
Listed alongside Peter Rhode (17 shared filings), Fred Middleton (12 shared filings), C. Boyden Gray (9 shared filings), Rick S. Greene (7 shared filings), Bee-Yau Huang (6 shared filings) and 11 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Hing. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 17 public filings for Hing C. Wong and found 12 differences, 3 worth asking the sponsor about: Amount sold went down between filings; Investor count went down between filings; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.